Furthermore, we have previously demonstrated that inhibition of GCS can reduce glycosphingolipid levels and pathological α-synuclein inclusions in the brain and ameliorate the associated cognitive deficits in mouse models of synucleinopathy27. Here, UGCG is linked to Cognitive impairment.